Cargando…

Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study

BACKGROUND: Outcomes of retreatment for rifampicin-resistant tuberculosis (RR-TB) are rarely reported. We report ‘definitive outcomes’ after a cascade approach to RR-TB treatment. After a bacteriologically adverse outcome for the 9-months fluoroquinolone-based Short Treatment Regimen (STR), patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souleymane, Mahamadou Bassirou, Decroo, Tom, Mamadou, Saïdou, Soumana, Alphazazi, Lawan, Ibrahim Mamane, Gagara-Issoufou, Assiatou, Adehossi, Eric, Ortuño-Gutiérrez, Nimer, Lynen, Lutgarde, Rigouts, Leen, de Jong, Bouke Catherine, Van Deun, Armand, Piubello, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10153560/ https://www.ncbi.nlm.nih.gov/pubmed/35420123 http://dx.doi.org/10.1093/inthealth/ihac016

Ejemplares similares

Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation
por: Souleymane, Mahamadou Bassirou, et al.
Publicado: (2022)

High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
por: Decroo, Tom, et al.
Publicado: (2020)

The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance
por: Van Deun, Armand, et al.
Publicado: (2020)

False Rifampicin Resistance in Xpert Ultra Applied to Lymph Node Aspirate: A Case Report
por: Ng, Kamela C S, et al.
Publicado: (2020)

Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi
por: Ciza, François, et al.
Publicado: (2020)

Bedaquiline can act as core drug in a standardised treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis
por: Decroo, Tom, et al.
Publicado: (2022)

Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes
por: Decroo, Tom, et al.
Publicado: (2020)

Evaluating the Effectiveness of a Novel Systematic Screening Approach for Tuberculosis among Individuals Suspected or Recovered from COVID-19: Experiences from Niger and Guinea
por: Magassouba, Aboubacar Sidiki, et al.
Publicado: (2022)

Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings
por: Van Deun, Armand, et al.
Publicado: (2022)

Community-supported self-administered tuberculosis treatment combined with active tuberculosis screening: a pilot experience in Conakry, Guinea
por: Hassane-Harouna, Souleymane, et al.
Publicado: (2023)

Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study
por: Hassane-Harouna, Souleymane, et al.
Publicado: (2020)

Case Report: Therapeutic Threshold for Rifampicin-Resistant Tuberculosis in a Patient from Maputo, Mozambique
por: Gonzaga, Lorena D. M., et al.
Publicado: (2021)

Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
por: Van Deun, Armand, et al.
Publicado: (2021)

Dynamic relationship of traditional soil restoration practices and climate change adaptation in semi-arid Niger
por: Issoufou, Abdourhimou Amadou, et al.
Publicado: (2020)

Low Cycle Threshold Value in Xpert MTB/RIF Assay May Herald False Detection of Tuberculosis and Rifampicin Resistance: A Study of Two Cases
por: Ngabonziza, Jean Claude S, et al.
Publicado: (2021)

Outcomes of a nine-month regimen for rifampicin-resistant tuberculosis up to 24 months after treatment completion in nine African countries
por: Schwœbel, Valérie, et al.
Publicado: (2020)

Face mask sampling (FMS) for tuberculosis shows lower diagnostic sensitivity than sputum sampling in Guinea
por: Hassane-Harouna, Souleymane, et al.
Publicado: (2023)

Temporary disengagement and re-engagement in human immunodeficiency virus care in a rural county serving pastoralist communities in Kenya: a retrospective cohort study
por: Yonga, Paul, et al.
Publicado: (2019)

Inter and intra cultural variations of millet (Pennisetum glaucum (L.) R. Br) uses in Niger (West Africa)
por: Moussa, Hamadou, et al.
Publicado: (2019)

HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa
por: Mamadou, Saïdou, et al.
Publicado: (2012)

Correction to: Inter and intra cultural variations of millet (Pennisetum glaucum (L.) R. Br) uses in Niger (West Africa)
por: Moussa, Hamadou, et al.
Publicado: (2019)

Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen
por: Lempens, Pauline, et al.
Publicado: (2020)

Person‐centred care and short oral treatment for rifampicin‐resistant tuberculosis improve retention in care in Kandahar, Afghanistan
por: Mesic, Anita, et al.
Publicado: (2022)

Epidemiological, clinical and biological features of malaria among children in Niamey, Niger
por: Gay-Andrieu, Françoise, et al.
Publicado: (2005)

Analyse multicentrique de la qualité rédactionnelle des bulletins d’analyses biologiques au Niger
por: Djobo, Kadour, et al.
Publicado: (2022)

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
por: Trébucq, Arnaud, et al.
Publicado: (2019)

Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts
por: Younoussa, Assoumani, et al.
Publicado: (2023)

1319. Events of Disengagement from HIV care and Subsequent Reengagement in a Kenyan Pastoralist Community: Frequency, Determinants, and Patient Views
por: Yonga, Paul Otieno, et al.
Publicado: (2019)

Borderline rpoB mutations transmit at the same rate as common rpoB mutations in a tuberculosis cohort in Bangladesh
por: Lempens, Pauline, et al.
Publicado: (2023)

Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance
por: Torrea, Gabriela, et al.
Publicado: (2019)

Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold
por: Decroo, Tom, et al.
Publicado: (2017)

Farmers' perceptions of fodder performances of pearl millet (Pennisetum glaucum (L.) R. Br) accessions in Niger
por: Moussa, Hamadou, et al.
Publicado: (2021)

Thin-Layer-Agar-Based Direct Phenotypic Drug Susceptibility Testing on Sputum in Eswatini Rapidly Detects Mycobacterium tuberculosis Growth and Rifampicin Resistance Otherwise Missed by WHO-Endorsed Diagnostic Tests
por: Ardizzoni, E., et al.
Publicado: (2021)

GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis
por: Rigouts, Leen, et al.
Publicado: (2023)

Serological Prevalence of Contagious Bovine Pleuropneumonia in Niger in 2017
por: Yansambou, Mahamadou Seyni, et al.
Publicado: (2018)

Laboratory organisation and management of SARS-CoV-2 infection in Niger, West Africa
por: Yacouba, Abdourahamane, et al.
Publicado: (2020)

Hygienic quality of raw and fermented cow milk in the local milk sector of the Liptako-Gourma area in Niger
por: Gagara, Mariama Hima, et al.
Publicado: (2022)

Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide
por: Ngabonziza, Jean Claude Semuto, et al.
Publicado: (2017)

Profil épidémiologique, clinique et évolutif des patients tuberculeux au Centre Hospitalier Régional (CHR) de Maradi, République du Niger
por: Amadou, Mahaman Laouali Harouna, et al.
Publicado: (2019)

Predictors of Rifampicin-Resistant Tuberculosis Mortality among HIV-Coinfected Patients in Rwanda
por: Habimana, Dominique Savio, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8175uovgl5sds5g009k67mrjpr